Thyroid Cancer clinical trials in Georgia

5 actively recruiting thyroid cancer trials at 8 sites across Georgia.

Data from ClinicalTrials.gov · last refreshed 2026-04-20

Phase 1, Phase 2 Recruiting Industry

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Phase 1 dose escalation will determine the first cycle dose-limiting toxicities (DLTs), the maximum tolerated dose (MTD), the biologically effective dose and recommended Phase 2 dose (RP2D) of repotrectinib given to adult subjects with adv…

Sponsor: Turning Point Therapeutics, Inc.

NCT ID: NCT03093116

Sites in Georgia:

University Cancer and Blood Center — Athens, Georgia
Local Institution - 2134 — Columbus, Georgia

View on ClinicalTrials.gov →

Recruiting Academic/Other

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in th…

Sponsor: Alliance for Clinical Trials in Oncology

NCT ID: NCT05334069

Sites in Georgia:

Northeast Georgia Medical Center Braselton — Braselton, Georgia
Atlanta VA Medical Center — Decatur, Georgia
Northeast Georgia Medical Center-Gainesville — Gainesville, Georgia
The Longstreet Clinic - Gainesville — Gainesville, Georgia
Low Country Cancer Care — Savannah, Georgia

View on ClinicalTrials.gov →

NA Recruiting Network

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

The purpose of this study is to evaluate feasibility and acceptability of completing PROs among AYAs randomized to Choice PRO vs Fixed PRO.

Sponsor: Eastern Cooperative Oncology Group

NCT ID: NCT05108298

Sites in Georgia:

Lewis Cancer and Research Pavilion at Saint Joseph's/Candler — Savannah, Georgia

View on ClinicalTrials.gov →

Recruiting Industry

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

This is an observational case-control study to train and validate a genome-wide methylome enrichment platform to detect multiple cancer types and to differentiate amongst cancer types. The cancers included in this study are brain, breast, …

Sponsor: Adela, Inc

NCT ID: NCT05366881

Sites in Georgia:

North Georgia Health System — Gainesville, Georgia

View on ClinicalTrials.gov →

Recruiting Academic/Other

Targeted Therapy to Increase RAI Uptake in Metastatic DTC

Papillary thyroid cancer (PTC) is a common type of differentiated thyroid cancer (DTC) in children and represents the second most common cancer in adolescent females. Recently targeted drugs that block many of the genetic drivers of DTC ha…

Sponsor: Children's Hospital of Philadelphia

NCT ID: NCT05024929

Sites in Georgia:

Emory University School of Medicine — Atlanta, Georgia

View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-04-20